Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo

Leukemia. 2018 Aug;32(8):1834-1837. doi: 10.1038/s41375-018-0126-9. Epub 2018 Apr 2.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Transformation, Neoplastic
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Leukemia, Experimental / genetics
  • Leukemia, Experimental / pathology
  • Leukemia, Experimental / prevention & control*
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / pathology
  • Leukemia, Myeloid / prevention & control*
  • Mice
  • Mice, Transgenic
  • Mutation*
  • Repressor Proteins / genetics
  • Repressor Proteins / metabolism*
  • Tumor Suppressor Proteins / deficiency*
  • Ubiquitin Thiolesterase / deficiency*

Substances

  • Asxl1 protein, mouse
  • BAP1 protein, mouse
  • Repressor Proteins
  • Tumor Suppressor Proteins
  • Ubiquitin Thiolesterase